Category: Covidien
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Hospital group purchasing organization Novation awards new contracts for cardiovascular products to a clutch of market leaders.
Group purchasing organization Novation awarded new cardiovascular contracts to a host of market leaders, effective at the beginning of 2013.
Covidien updates investors on the planned spinout of its pharmaceuticals business, expected by mid-2013.
With strong fiscal 2012 numbers under its belt, Covidien (NYSE:COV) updated investors today on its expected financials after it spins out its pharmaceuticals business next year.
The Mansfield, Mass.-based medical device company said late last year that it planned to ditch the no-or-low-growth pharma unit, which will become a stand-alone operation.
Shares of Covidien are up 5% today after the medical device company reported strong fiscal 2012 results and reaffirmed its outlook for fiscal 2013.
Covidien (NYSE:COV) shares got a jolt on Wall Street this morning after the medical device company reported strong fiscal 2012 results and confirmed its outlook for next year.
Investors had added 5.3% to COV's price as of about 11:45 this morning, sending shares to $56.18 despite a nearly 3% sales slide that just beat expectations on The Street.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Covidien lands 510(k) clearance for its Nellcor bedside respiratory patient monitoring system, which aims to reduce costs and service disruptions.
Medical device company Covidien (NYSE:COV) landed FDA 510(k) clearance and European CE Mark approval for the Nellcor bedside respiratory patient monitoring system, which will help clinicians detect and respond to dangerous respiratory events sooner, the company said.
